Internal Medicine, Gastroenterology · Corsicana, TX
NPI
1144257056
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
400 Hospital Dr, Ste 207
Corsicana, TX, 75110
Phone (903) 654-4880
Groups this clinician bills Medicare through
Medicare paid, 2024
$58K
558 services
Medicare patients, 2024
334
Average age 71
Drug cost, 2024
$127K
1,487 prescriptions
Company payments, 2025
$178
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shahzad M Syed was code 45380 (lower gi endoscopy - other), 119 times for 119 patients. In total Shahzad M Syed billed 558 services in 20 codes, and Medicare paid $58K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45380 Lower GI Endoscopy - Other | Facility | 119 | 119 | $65.95 | $7,848 |
| 45385 Colonoscopy - Lesion Removal | Facility | 110 | 110 | $198.89 | $22K |
| 99213 Office E&M - Established | Office | 69 | 64 | $60.97 | $4,207 |
| 99203 Office E&M - New | Office | 49 | 49 | $70.84 | $3,471 |
| 99214 Office E&M - Established | Office | 45 | 40 | $76.60 | $3,447 |
| 43239 Upper GI Endoscopy | Facility | 40 | 40 | $86.31 | $3,453 |
| 99204 Office E&M - New | Office | 36 | 36 | $98.43 | $3,543 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 26 | 26 | $174.28 | $4,531 |
| 45384 Colonoscopy - Lesion Removal | Facility | 21 | 21 | $70.61 | $1,483 |
By year: 2022 $78K for 885 services; 2023 $65K for 716 services; 2024 $58K for 558 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shahzad M Syed prescribed most often to Medicare patients was Pantoprazole Sodium, with 526 prescriptions and refills. In total Shahzad M Syed wrote 1,487 Medicare prescriptions that cost $127K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 526 | 913 | 133 | $3,999 |
| Ondansetron Odt Ondansetron | 242 | 242 | 236 | $820 |
| Famotidine Generic | 182 | 296 | 47 | $1,614 |
| Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 173 | 173 | 171 | $24K |
| Dexlansoprazole Dr Dexlansoprazole | 73 | 98 | 17 | $14K |
| Linzess Linaclotide | 72 | 101 | 22 | $56K |
| Omeprazole Generic | 66 | 130 | 24 | $608 |
| Mesalamine Generic | 22 | 24 | Under 11 | $6,898 |
| Trulance Plecanatide | 15 | 15 | Under 11 | $8,538 |
| Sucralfate Generic | 13 | 15 | Under 11 | $246 |
| Dicyclomine Hcl Generic | 12 | 12 | Under 11 | $58.37 |
| Esomeprazole Magnesium Generic | 11 | 17 | Under 11 | $239 |
Brand drugs: 294 claims; generic drugs: 1,193 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shahzad M Syed $178 ($178 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $178.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 14 | $178 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.